What is the recommended needle size and gauge for intramuscular (IM) injections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Needle Size and Gauge for Intramuscular Injections

For intramuscular (IM) injections in adults, a 22-25 gauge needle with length of 1-1.5 inches is recommended, with specific adjustments based on patient size, injection site, and age. 1

Needle Selection by Age Group

Infants (< 12 months)

  • 22-25 gauge, 7/8-1 inch needle for anterolateral thigh (preferred site) 1
  • Subcutaneous injections: 23-25 gauge, 5/8 inch needle 1

Toddlers and Children (12 months-18 years)

  • 22-25 gauge, 7/8-1¼ inch needle for deltoid or anterolateral thigh 1
  • Deltoid can be used if muscle mass is adequate 1

Adults (≥19 years)

  • Weight-based needle length recommendations:
    • Adults <60 kg (130 lbs): 25 mm (1 inch) needle 1
    • Adults 60-70 kg (130-152 lbs): 25 mm (1 inch) needle 1
    • Men 70-118 kg (152-260 lbs): 25-38 mm (1-1½ inches) needle 1
    • Women 70-90 kg (152-200 lbs): 25-38 mm (1-1½ inches) needle 1
    • Men >118 kg (260 lbs): 38 mm (1½ inches) needle 1
    • Women >90 kg (200 lbs): 38 mm (1½ inches) needle 1

Needle Selection by Injection Site

Deltoid Site

  • Adults: 22-25 gauge, 1-1½ inch needle 1
  • Consider arm circumference: use longer needle (>1 inch) when arm circumference exceeds 35 cm for men and 30 cm for women 2

Anterolateral Thigh

  • Infants and children: 22-25 gauge, 7/8-1¼ inch needle 1
  • Adults: 22-25 gauge, 1-1½ inch needle 1

Ventrogluteal/Dorsogluteal Sites

  • Adults: 22-23 gauge, 1½ inch needle 1, 3
  • For obese patients: Consider needle longer than 1.5 inches, especially for women with BMI >24.9 kg/m² 3
  • Note: Buttock should not be used for vaccine administration due to risk of sciatic nerve injury and decreased immunogenicity 1

Special Considerations for Obese Patients

  • Subcutaneous tissue thickness increases with BMI, requiring longer needles to reach muscle 1, 3
  • For women with BMI >24.9 kg/m², use needles longer than 1.5 inches for gluteal injections 3
  • In extremely obese patients, subcutaneous tissue thickness can exceed 50 mm at gluteal sites 3
  • Consider using deltoid site in obese patients when possible, as it has less subcutaneous tissue 4, 3

Injection Technique Tips

  • Insert needle at 90-degree angle to ensure proper muscle penetration 1
  • For patients at risk of IM injection (children, thin adults), use a lifted skinfold technique 1
  • Needle should be long enough to reach muscle mass but not so long as to involve nerves, blood vessels, or bone 1
  • The ventrogluteal site is farther from neurovascular structures (11.82 ± 14 mm to superior gluteal nerve) compared to dorsogluteal site (5.67 ± 9 mm) 5

Common Pitfalls to Avoid

  • Using too short a needle in obese patients, resulting in subcutaneous rather than intramuscular deposition 4, 3
  • Using the dorsogluteal site for vaccinations (risk of sciatic nerve injury) 1
  • Using the same needle length for all patients regardless of body habitus 1, 3
  • Failing to consider site-specific differences in subcutaneous tissue thickness 1, 3

Remember that proper needle selection is crucial for ensuring medications reach the intended muscle tissue, which affects both efficacy and safety of the administered medication 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.